Press release
Guillain-Barre Syndrome Market Poised for 5.6 % Growth, Set to Hit $0.79 Billion by 2029
Guillain-Barre Syndrome
The increasing risk of immunological diseases is expected to drive the growth of the guillain-barré syndrome market. Immunological diseases, including autoimmune diseases, allergies, and immunodeficiencies, occur when the immune system is overactive, underactive, or misdirected. Environmental factors, lifestyle changes, better diagnoses, and genetic predisposition are contributing to the rise of immunological diseases. These conditions can trigger guillain-barré syndrome when the immune system attacks peripheral nerves, causing inflammation and nerve damage. For example, a report from the Joint United Nations Programme on HIV/AIDS (UNAIDS) in July 2024 indicated that by the end of 2022, approximately 39.5 million people worldwide were living with HIV, with 1.3 million new infections and 630,000 AIDS-related deaths that year. In 2023, the number of people living with HIV rose to approximately 39.9 million. The increasing risk of immunological diseases, such as HIV, is expected to propel the guillain-barré syndrome market.
Get Your Guillain-Barre Syndrome Market Report Here:
https://www.thebusinessresearchcompany.com/report/guillain-barre-syndrome-global-market-report
What growth opportunities are expected to drive the guillain-barre syndrome market's CAGR through 2034?
The Guillain-Barré syndrome (GBS) market has grown steadily, increasing from $0.60 billion in 2024 to $0.64 billion in 2025 at a CAGR of 5.9%. The expansion is due to rising demand for GBS treatments, increased viral infections, global vaccination efforts, improved understanding of autoimmune mechanisms, and greater awareness and diagnosis.
The Guillain-Barré syndrome market size is set to grow considerably in the coming years, reaching $0.79 billion by 2029 at a CAGR of 5.6%. Growth drivers in this period include the rising prevalence of Guillain-Barré syndrome, the impact of climate change, increased use of immunotherapies and medications, enhanced diagnostic capabilities, and the growing occurrence of multifocal motor neuropathy. Major trends anticipated include advancements in diagnostic techniques, the development of immunoglobulin therapies, enhancements in plasmapheresis methods, research into gene therapy, a stronger focus on early intervention, novel biomarkers for prognosis, and expanded clinical trials exploring innovative treatments.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21198&type=smp
What are the emerging trends shaping the future of the guillain-barre syndrome market?
In the Guillain-Barré syndrome (GBS) market, companies are leveraging monoclonal antibodies to improve treatment efficacy and meet unmet clinical needs. Monoclonal antibodies are engineered to target specific antigens to modulate immune responses and improve therapeutic outcomes. In October 2023, Annexon Inc., a US-based biopharmaceutical company, received orphan drug designation from the European Medicines Agency (EMA) for its drug ANX005, a monoclonal antibody targeting C1q. Early clinical trials showed that ANX005 improved muscle strength and reduced the need for ventilation in GBS patients, marking a significant step forward in treatment options.
Which growth-oriented segments of the guillain-barre syndrome market are leading the industry's development?
The guillain-barre syndrome market covered in this report is segmented -
1) By Type: Acute Inflammatory Demyelinating Polyneuropathy (AIDP), Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP), Miller Fisher Syndrome (MFS), Acute Motor Axonal Neuropathy (AMAN), Other Types
2) By Therapeutics: Intravenous Immunoglobulin (IVIG), Plasma Exchange, Other Therapeutics
3) By Route Of Administration: Parenteral, Oral
4) By End User: Hospitals, Clinics, Diagnostic Centers, Other End Users
Subsegments:
1) By Acute Inflammatory Demyelinating Polyneuropathy (AIDP): Classical AIDP, AIDP with Autonomic Involvement
2) By Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP): Progressive CIDP, Relapsing-Remitting CIDP, Multifocal CIDP
3) By Miller Fisher Syndrome (MFS): Classical MFS, MFS With Ataxia, MFS With Ophthalmoplegia
4) By Acute Motor Axonal Neuropathy (AMAN): Classical AMAN, AMAN with Respiratory Involvement
5) By Other Types: Acute Sensory Ganglionopathy, Variants With Cranial Nerve Involvement, Bickerstaff Brainstem Encephalitis
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21198
What regions are leading the charge in the guillain-barre syndrome market?
North America was the largest region in the guillain-barre syndrome market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the guillain-barre syndrome market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What companies are at the forefront of innovation in the guillain-barre syndrome market?
Major companies operating in the guillain-barre syndrome market are Pfizer Inc., Roche AG, Thermo Fisher Scientific Inc., AstraZeneca PLC, GSK plc, Takeda Pharmaceutical Company Limited, Merck & Co. Inc., Baxter International Inc., Biogen Inc., Horizon Therapeutics, Octapharma AG, Kedrion S.p.A., Annexon Inc., Immunovant Inc., CSL Behring LLC, Hansa Biopharma AB, NeuLine Health Inc., Ridge Diagnostics Inc., Deymed Diagnostic LLC, VYVGART Hytrulo.
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=21198&type=smp
What Is Covered In The Guillain-Barre Syndrome Global Market Report?
•Market Size Forecast: Examine the guillain-barre syndrome market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the guillain-barre syndrome market for a structured understanding.
•Key Players Overview: Analyze major players in the guillain-barre syndrome market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the guillain-barre syndrome market.
•Segment Contributions: Evaluate how different segments drive overall growth in the guillain-barre syndrome market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the guillain-barre syndrome market.
•Industry Challenges: Identify potential risks and obstacles affecting the guillain-barre syndrome market.
•Competitive Landscape: Review strategic developments in the guillain-barre syndrome market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Guillain-Barre Syndrome Market Poised for 5.6 % Growth, Set to Hit $0.79 Billion by 2029 here
News-ID: 3934479 • Views: …
More Releases from The Business Research Company
Unlocking Opportunities in the Tyrosine Kinase Inhibitors Market: 2025-2034 Fore …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Tyrosine Kinase Inhibitors Industry Market Size Be by 2025?
The market for tyrosine kinase inhibitors has seen robust growth in recent times. The market is predicted to expand from $58.03 billion in 2024 to $62.66 billion in 2025, marking a compound annual growth rate (CAGR) of…
Sustained Release Excipients Market Advances With Product Innovation Industry Tr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Sustained Release Excipients Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, the market size of sustained release excipients has seen significant growth. It's projected to increase from $1.4 billion in 2024 to $1.51 billion in 2025, exhibiting a Compound Annual Growth Rate…
Surge In Cancer Cases Fuels Expansion Of The RNA-Targeting Small Molecule Therap …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the RNA Targeting Small Molecules Therapeutics Market Size By 2025?
In recent years, the market size of RNA targeting small molecules therapeutics has witnessed substantial growth. The market, which is estimated to be worth $6.1 billion in 2024, is projected to increase to $7.83 billion in…
Surge In Autoimmune Diseases Fuels Remicade Biosimilar Market Growth Emerges as …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Remicade Biosimilar Market Through 2025?
In recent times, we've seen significant expansion in the remicade biosimilar market. Projected growth from 2024's $3.95 billion to $4.89 billion in 2025 indicates a compound annual growth rate (CAGR) of 23.8%. This rise during the historic…
More Releases for Syndrome
"Understanding Rett Syndrome: Trends and Advances in the Rett Syndrome Market"
The Rett Syndrome Market, valued at USD 225.02 million in 2022, is anticipated to surge to USD 515.06 million by 2029, reflecting a significant Compound Annual Growth Rate (CAGR) of 10.23% from 2023 to 2029.
Overview of the Rett Syndrome Market:
Rett syndrome, a rare genetic neurological and developmental disorder primarily impacting females, hinders brain development and causes progressive loss of motor skills and language. The market report underscores technological advancements…
MISME Syndrome Market - Navigating Challenges, Embracing Abilities: MISME Syndro …
Newark, New Castle, USA: The "MISME Syndrome Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
MISME Syndrome Market: https://www.growthplusreports.com/report/misme-syndrome-market/8883
This latest report researches the industry structure, sales, revenue,…
Felty Syndrome Market - A Dedicated Approach to Felty Syndrome Care and Empowerm …
Newark, New Castle, USA: The "Felty Syndrome Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Felty Syndrome Market: https://www.growthplusreports.com/report/felty-syndrome-market/8440
This latest report researches the industry structure, sales, revenue,…
MISME Syndrome Market - Transforming Lives: Empowering Recovery from MISME Syndr …
Newark, New Castle, USA - new report, titled MISME Syndrome Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the MISME Syndrome market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global MISME Syndrome market. The report offers an overview of the market, which…
Hepatorenal Syndrome Market - Reimagining Wellness, Redefining Survival: Hepator …
Newark, New Castle, USA - new report, titled Hepatorenal Syndrome Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Hepatorenal Syndrome market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Hepatorenal Syndrome market. The report offers an overview of the market, which…
Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syn …
Global Markets Directs, Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome) - Pipeline Review, H2 2016, provides an overview of the Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome) pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and…
